Tremfya subcutaneous injection 100mg syringe, manufactured by Janssen Pharmaceutical, contains Guselkumab (genetical recombination) (YJ code: 3999446G1021, 100mg 1mL 1 tube). This interleukin-23 (IL-23) inhibitor is used to treat moderate to severe plaque psoriasis and active psoriatic arthritis in adult patients.
Tremfya subcutaneous injection 100mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).